Drug Type Probiotics |
Synonyms NC 001, NC001 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Preclinical | South Korea | 01 Aug 2025 | |
Mucositis | Preclinical | South Korea | 01 Aug 2025 | |
Rheumatoid Arthritis | Preclinical | South Korea | 01 Apr 2025 | |
Tuberculosis | Preclinical | South Korea | 01 Apr 2025 | |
Xanthomatosis, Cerebrotendinous | Preclinical | South Korea | 01 Apr 2025 |